2017
Survival benefit needed to undergo chemotherapy: Patient and physician preferences
Vaz‐Luis I, O'Neill A, Sepucha K, Miller KD, Baker E, Dang CT, Northfelt DW, Winer EP, Sledge GW, Schneider B, Partridge AH. Survival benefit needed to undergo chemotherapy: Patient and physician preferences. Cancer 2017, 123: 2821-2828. PMID: 28323331, PMCID: PMC5517352, DOI: 10.1002/cncr.30671.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAntineoplastic Combined Chemotherapy ProtocolsAttitude of Health PersonnelAttitude to HealthBevacizumabBreast NeoplasmsChemotherapy, AdjuvantClinical Trials, Phase III as TopicCyclophosphamideDoxorubicinFemaleHumansMastectomyMastectomy, SegmentalMiddle AgedPaclitaxelPatient PreferencePhysiciansQuality of LifeRandomized Controlled Trials as TopicRisk AssessmentSurveys and QuestionnairesSurvival RateTumor BurdenConceptsMonths of chemotherapyModest survival benefitSurvival benefitAdjuvant chemotherapyEarly-stage breast cancerContemporary adjuvant chemotherapyPhase 3 trialBreast cancer patientsStage breast cancerQuality of lifeMonths of benefitsAdjuvant cyclophosphamideAdjuvant doxorubicinChemotherapy regimenMost patientsUndergoing ChemotherapyCancer patientsPatient preferencesBreast cancerModest benefitOld regimenChemotherapyPatientsPhysician's choiceSerial surveys
2015
Variation in the Attitudes of Medical Oncologists Toward Research Biopsies in Patients With Metastatic Breast Cancer
Seah DS, Scott S, Guo H, Najita J, Lederman R, Frank E, Sohl J, Stadler Z, Silverman S, Peppercorn J, Winer E, Come S, Lin NU. Variation in the Attitudes of Medical Oncologists Toward Research Biopsies in Patients With Metastatic Breast Cancer. The Oncologist 2015, 20: 992-1000. PMID: 26240134, PMCID: PMC4571800, DOI: 10.1634/theoncologist.2015-0112.Peer-Reviewed Original ResearchConceptsMetastatic breast cancerBiopsy-related painResearch biopsiesMBC patientsMedical oncologistsOncologists' attitudesBreast cancerWillingness of patientsNational Cancer InstituteEligible respondersModifiable factorsAdditional biopsiesCancer CenterNCI centersPatients' willingnessCommon reasonBiopsyCancer InstitutePatientsSelf-administered surveyStandalone procedureTumor biologyAvailability of tissueElicit factorsPotential target
2008
Perceptions and Management Approaches of Physicians Who Care for Women with Ductal Carcinoma In Situ
Partridge A, Winer JP, Golshan M, Bellon JR, Blood E, Dees EC, Sampson E, Emmons KM, Winer E. Perceptions and Management Approaches of Physicians Who Care for Women with Ductal Carcinoma In Situ. Clinical Breast Cancer 2008, 8: 275-280. PMID: 18650159, DOI: 10.3816/cbc.2008.n.032.Peer-Reviewed Original ResearchConceptsDuctal carcinomaBreast cancerOverall healthPatient's overall healthLongitudinal cohort studyCohort studyMedian ageMedical oncologistsEligible physiciansPatient outcomesMultivariable modelPhysicians' perceptionsDCISNew patientsPatientsResponse rateFurther evaluationTheoretical patientsPhysiciansWomenMore womenCarcinomaCancerRisky diseaseRisk
2004
Oncology Physician and Nurse Practices and Attitudes Regarding Offering Clinical Trial Results To Study Participants
Partridge AH, Hackett N, Blood E, Gelman R, Joffe S, Bauer-Wu S, Knudsen K, Emmons K, Collyar D, Schilsky RL, Winer EP. Oncology Physician and Nurse Practices and Attitudes Regarding Offering Clinical Trial Results To Study Participants. Journal Of The National Cancer Institute 2004, 96: 629-632. PMID: 15100341, DOI: 10.1093/jnci/djh096.Peer-Reviewed Original ResearchConceptsTrial resultsMost patientsOncology physiciansClinical trialsClinical trial resultsOncology clinical trialsPatientsEligible membersNurses' practicePatients' difficultiesRespondersNegative emotional effectsTrialsPhysiciansFuture studiesOne-fifthParticipantsStudy resultsCancerCliniciansNursesResults of studiesEmotional effects